COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,160 Articles (22,703 medRxiv, 8,457 bioRxiv)

Most recent first Previous |  Page 929: Articles 9281-9290  | Next

Evaluation of a Rapid and Accessible RT-qPCR Approach for SARS-CoV-2 Variant of Concern Identification
Yeung, P. S.- W., Wang, H., Sibai, M., Solis, D., Yamamoto, F., Iwai, N., Jiang, B., Hammond, N., Truong, B., Bihon, S., Santos, S., Mar, M., Mai, C., Kenji, O. M., Mfuh, K. O., Miller, J., Huang, C., Sahoo, M. K., Zehnder, J., Pinsky, B. A.
10.1101/2022.02.07.22270629 — Posted: 2022-02-08
Evaluating Fomite Risk of Brown Paper Bags Storing Personal Protective Equipment Exposed to SARS-CoV-2: A Quasi-Experimental Study
Unger, K., Dietz, L., Horve, P. F., Lin, A., Van Den Wymelenberg, K. G., Kea, B., Kinney, E.
10.1101/2022.02.07.22270332 — Posted: 2022-02-08 Discussion: Onsite
Deploying wearable sensors for pandemic mitigation
Duarte, N., Arora, R., Bennett, G., Wang, M., Snyder, M. P., Cooperstock, J. R., Wagner, C. E.
10.1101/2022.02.07.22270634 — Posted: 2022-02-08
Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in Australia: a Bayesian network analysis
Sinclair, J. E., Mayfield, H. J., Short, K. R., Brown, S. J., Puranik, R., Mengersen, K., Litt, J. C., Lau, C. L.
10.1101/2022.02.07.22270637 — Posted: 2022-02-08 Discussion: Onsite
Rapid, High-Throughput, Cost Effective Whole Genome Sequencing of SARS-CoV-2 Using a Condensed One Hour Library Preparation of the Illumina DNA Prep Kit
Hickman, R., Nguyen, J., Lee, T. D., Tyson, J. R., Azana, R., Tsang, F., Hoang, L., Prystajecky, N.
10.1101/2022.02.07.22269672 — Posted: 2022-02-08
Antibody and memory B-cell immunity in a heterogeneously SARS-CoV-2 infected and vaccinated population
Bednarski, E., Del Rio Estrada, P. M., DaSilva, J., Boukadida, C., Zhang, F., Luna Villalobos, Y. A., Rodriguez Range, X., Piten Isidro, E., Luna Garcia, E., Diaz Rivera, D., Lopez Sanchez, D. M., Tapia Trejo, D., Soto-Nava, M., Astorga Castaneda, M., Martinez Moreno, J. O., Urbina Granados, G. S., Jimenez Jacinto, J. A., Serna Alvarado, F. J., Enriquez Lopez, Y. E., Lopez Arellano, O., Reyes Teran, G., Bieniasz, P. D., Avila Rios, S., Hatziioannou, T.
10.1101/2022.02.07.22270626 — Posted: 2022-02-08 Discussion: Offsite
Clinical and Economic Impact of COVID-19 on Plantation Workers: Preliminary Results from the Guatemala Agricultural Workers and Respiratory Illness Impact (AGRI) Study
Olson, D., Calvimontes, D. M., Lamb, M. M., Guzman, G., Barrios, E., Chacon, A., Rojop, N., Arias, K., Gomez, M., Bolanos, G. A., Monzon, J., Chard, A. N., Iwaomto, C., Duca, L. M., Vuong, N., Fineman, M., Lesteberg, K., Beckham, D., Santiago, M. L., Quicke, K., Ebel, G., Zielinski Gutierrez, E., Azziz-Baumgartner, E., Hayden, F. G., Mansour, H., Edwards, K., Newman, L. S., Asturias, E. J.
10.1101/2022.02.07.22270274 — Posted: 2022-02-08
A highly attenuated SARS-CoV-2 related pangolin coronavirus variant has a 104nt deletion at the 3'-terminus untranslated region
Lu, S., Luo, S., Liu, C., Li, M., An, X., Li, M., Hou, J., Fan, H., Mao, P., Tong, Y.-G., Song, L.
10.1101/2022.02.07.479352 — Posted: 2022-02-08
Spike Protein-independent Attenuation of SARS-CoV-2 Omicron Variant in Laboratory Mice
Liu, S., Selvaraj, P., Sangare, K., Luan, B., Wang, T. T.
10.1101/2022.02.08.479543 — Posted: 2022-02-08
Anti-spike antibody trajectories in individuals previously immunised with BNT162b2 or ChAdOx1 following a BNT162b2 booster dose
Yavlinsky, A., Beale, S., Nguyen, V., Shrotri, M., Byrne, T. E., Geismar, C., Fragaszy, E., Hoskins, S. J., Fong, W. L. E., Navaratnam, A. M. D., Braithwaite, I., Patel, P., Kovar, J., Hayward, A. C., Aldridge, R. W.
10.1101/2022.02.07.22270451 — Posted: 2022-02-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).